Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

By LabMedica International staff writers
Posted on 01 Jun 2023

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. More...

TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through tiny respiratory droplets when a TB-infected individual coughs, sneezes, or talks. Given its high contagion rate, one of the key strategies to curb TB is the early identification of infected patients, thus preventing further spread. Existing TB testing methods, while beneficial, present several drawbacks such as low sensitivity, prolonged wait times for results, and the necessity for specialized lab personnel. To combat these challenges, a research team has created a highly sensitive strip test that can detect TB within two hours.

The MTB Strip TB Test Kit developed by researchers at Chulalongkorn University (Bangkok, Thailand) leverages the technique of genetic material amplification at a constant temperature, alongside a heat box, a common piece of equipment in most labs. This approach is even accessible to small-scale hospitals. To use the MTB Strip TB Test Kit, the patient's sputum is first collected, from which DNA is extracted for use as a template. A specially-crafted primer is used to amplify the genetic material in the pathogen's DNA present in the patient's sputum, a process facilitated by a recombinase polymerase amplification technique that takes merely 20-40 minutes at 37 degrees Celsius. The resulting amplified genetic material is then introduced to the test strip, which displays positive or negative results.

The MTB Strip delivers results with an accuracy rate of up to 96% compared to Realtime PCR and other commonly used acid-resistant dye methods. Moreover, the kit proves more cost-effective than molecular biology tests as it doesn't require specific tools such as a thermocycler. Notably, the MTB Strip demonstrates high sensitivity to TB, capable of detecting even minimal amounts of TB present in sputum. Furthermore, the test is user-friendly, delivers quick and precise results within an hour that can be easily read with the naked eye, and requires no specialized equipment. Despite the satisfactory performance of the MTB Strip kit, the researchers aim to enhance its sensitivity by simplifying the DNA extraction process for use as the kit primer. Currently, they are working on expanding TB and related disease testing by creating an easier-to-use DNA extraction kit and a TB test kit capable of identifying drug-resistant TB strains from the outset, thus allowing for more specific treatment plans.

“We are currently conducting in-depth research on the genetic modification of tuberculosis using a novel technique of genetic modification for a living organism called CRISPR Cas-9 Interference to modify certain TB genes, making the infection less aggressive and more responsive to antituberculosis drugs. CRISPR Cas-9 Interference can be used in conjunction with current antituberculosis drugs,” said Dr. Panan Ratthawongjirakul, Associate Professor at Chulalongkorn University.

Related Links:
Chulalongkorn University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.